As of 2024-09-13, the EV/EBITDA ratio of Accelerate Diagnostics Inc (AXDX) is -1.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AXDX's latest enterprise value is 68.30 mil USD. AXDX's TTM EBITDA according to its financial statements is -39.59 mil USD. Dividing these 2 quantities gives us the above AXDX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 16.9x - 21.1x | 18.6x |
| Forward P/E multiples | 20.8x - 22.2x | 21.4x |
| Fair Price | (36.09) - (36.63) | (34.82) |
| Upside | -2506.1% - -2541.8% | -2421.4% |
| Date | EV/EBITDA |
| 2024-09-12 | -1.73 |
| 2024-09-11 | -1.79 |
| 2024-09-10 | -1.79 |
| 2024-09-09 | -1.77 |
| 2024-09-06 | -1.86 |
| 2024-09-05 | -1.84 |
| 2024-09-04 | -1.94 |
| 2024-09-03 | -2.01 |
| 2024-08-30 | -2.02 |
| 2024-08-29 | -1.97 |
| 2024-08-28 | -1.96 |
| 2024-08-27 | -1.96 |
| 2024-08-26 | -1.92 |
| 2024-08-23 | -1.89 |
| 2024-08-22 | -1.86 |
| 2024-08-21 | -1.84 |
| 2024-08-20 | -1.83 |
| 2024-08-19 | -1.92 |
| 2024-08-16 | -1.90 |
| 2024-08-15 | -1.83 |
| 2024-08-14 | -1.86 |
| 2024-08-13 | -1.90 |
| 2024-08-12 | -1.84 |
| 2024-08-09 | -1.70 |
| 2024-08-08 | -1.68 |
| 2024-08-07 | -1.64 |
| 2024-08-06 | -1.58 |
| 2024-08-05 | -1.52 |
| 2024-08-02 | -1.59 |
| 2024-08-01 | -1.62 |
| 2024-07-31 | -1.64 |
| 2024-07-30 | -1.59 |
| 2024-07-29 | -1.59 |
| 2024-07-26 | -1.61 |
| 2024-07-25 | -1.56 |
| 2024-07-24 | -1.58 |
| 2024-07-23 | -1.60 |
| 2024-07-22 | -1.52 |
| 2024-07-19 | -1.50 |
| 2024-07-18 | -1.50 |
| 2024-07-17 | -1.52 |
| 2024-07-16 | -1.50 |
| 2024-07-15 | -1.52 |
| 2024-07-12 | -1.52 |
| 2024-07-11 | -1.50 |
| 2024-07-10 | -1.51 |
| 2024-07-09 | -1.52 |
| 2024-07-08 | -1.53 |
| 2024-07-05 | -1.52 |
| 2024-07-03 | -1.53 |